These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 32816619)

  • 21. Endotoxin Producers Overgrowing in Human Gut Microbiota as the Causative Agents for Nonalcoholic Fatty Liver Disease.
    Fei N; Bruneau A; Zhang X; Wang R; Wang J; Rabot S; Gérard P; Zhao L
    mBio; 2020 Feb; 11(1):. PubMed ID: 32019793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral Pathobiont-Induced Changes in Gut Microbiota Aggravate the Pathology of Nonalcoholic Fatty Liver Disease in Mice.
    Yamazaki K; Kato T; Tsuboi Y; Miyauchi E; Suda W; Sato K; Nakajima M; Yokoji-Takeuchi M; Yamada-Hara M; Tsuzuno T; Matsugishi A; Takahashi N; Tabeta K; Miura N; Okuda S; Kikuchi J; Ohno H; Yamazaki K
    Front Immunol; 2021; 12():766170. PubMed ID: 34707622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calorie-Restricted Mediterranean and Low-Fat Diets Affect Fatty Acid Status in Individuals with Nonalcoholic Fatty Liver Disease.
    Ristic-Medic D; Kovacic M; Takic M; Arsic A; Petrovic S; Paunovic M; Jovicic M; Vucic V
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33374554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose.
    Sun G; Jackson CV; Zimmerman K; Zhang LK; Finnearty CM; Sandusky GE; Zhang G; Peterson RG; Wang YJ
    BMC Gastroenterol; 2019 Mar; 19(1):41. PubMed ID: 30885145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Desulfovibrio vulgaris, a potent acetic acid-producing bacterium, attenuates nonalcoholic fatty liver disease in mice.
    Hong Y; Sheng L; Zhong J; Tao X; Zhu W; Ma J; Yan J; Zhao A; Zheng X; Wu G; Li B; Han B; Ding K; Zheng N; Jia W; Li H
    Gut Microbes; 2021; 13(1):1-20. PubMed ID: 34125646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diet-Independent Correlations between Bacteria and Dysfunction of Gut, Adipose Tissue, and Liver: A Comprehensive Microbiota Analysis in Feces and Mucosa of the Ileum and Colon in Obese Mice with NAFLD.
    Gart E; Souto Lima E; Schuren F; de Ruiter CGF; Attema J; Verschuren L; Keijer J; Salic K; Morrison MC; Kleemann R
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of different diets on intestinal microbiota and nonalcoholic fatty liver disease development.
    Liu JP; Zou WL; Chen SJ; Wei HY; Yin YN; Zou YY; Lu FG
    World J Gastroenterol; 2016 Aug; 22(32):7353-64. PubMed ID: 27621581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NOD2 in hepatocytes engages a liver-gut axis to protect against steatosis, fibrosis, and gut dysbiosis during fatty liver disease in mice.
    Cavallari JF; Pokrajac NT; Zlitni S; Foley KP; Henriksbo BD; Schertzer JD
    Am J Physiol Endocrinol Metab; 2020 Aug; 319(2):E305-E314. PubMed ID: 32516028
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Lee NY; Yoon SJ; Han DH; Gupta H; Youn GS; Shin MJ; Ham YL; Kwak MJ; Kim BY; Yu JS; Lee DY; Park TS; Park SH; Kim BK; Joung HC; Choi IS; Hong JT; Kim DJ; Han SH; Suk KT
    Gut Microbes; 2020 Jul; 11(4):882-899. PubMed ID: 31965894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
    Suk KT; Kim DJ
    Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut microbiota are linked to increased susceptibility to hepatic steatosis in low-aerobic-capacity rats fed an acute high-fat diet.
    Panasevich MR; Morris EM; Chintapalli SV; Wankhade UD; Shankar K; Britton SL; Koch LG; Thyfault JP; Rector RS
    Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G166-79. PubMed ID: 27288420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal 16S rRNA Sequencing Reveals Relationships among Alterations of Gut Microbiota and Nonalcoholic Fatty Liver Disease Progression in Mice.
    Zhuge A; Li S; Lou P; Wu W; Wang K; Yuan Y; Xia J; Li B; Li L
    Microbiol Spectr; 2022 Jun; 10(3):e0004722. PubMed ID: 35647690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcium Reduces Liver Injury in Mice on a High-Fat Diet: Alterations in Microbial and Bile Acid Profiles.
    Nadeem Aslam M; Bassis CM; Zhang L; Zaidi S; Varani J; Bergin IL
    PLoS One; 2016; 11(11):e0166178. PubMed ID: 27851786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gypenosides improve the intestinal microbiota of non-alcoholic fatty liver in mice and alleviate its progression.
    Huang X; Chen W; Yan C; Yang R; Chen Q; Xu H; Huang Y
    Biomed Pharmacother; 2019 Oct; 118():109258. PubMed ID: 31545283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniae.
    Yuan J; Chen C; Cui J; Lu J; Yan C; Wei X; Zhao X; Li N; Li S; Xue G; Cheng W; Li B; Li H; Lin W; Tian C; Zhao J; Han J; An D; Zhang Q; Wei H; Zheng M; Ma X; Li W; Chen X; Zhang Z; Zeng H; Ying S; Wu J; Yang R; Liu D
    Cell Metab; 2019 Oct; 30(4):675-688.e7. PubMed ID: 31543403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Jaboticaba (Myrciaria jaboticaba) powder consumption improves the metabolic profile and regulates gut microbiome composition in high-fat diet-fed mice.
    Soares E; Soares AC; Trindade PL; Monteiro EB; Martins FF; Forgie AJ; Inada KOP; de Bem GF; Resende A; Perrone D; Souza-Mello V; Tomás-Barberán F; Willing BP; Monteiro M; Daleprane JB
    Biomed Pharmacother; 2021 Dec; 144():112314. PubMed ID: 34634561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications.
    Jayakumar S; Loomba R
    Aliment Pharmacol Ther; 2019 Jul; 50(2):144-158. PubMed ID: 31149745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lingguizhugan decoction attenuates diet-induced obesity and hepatosteatosis
    Liu MT; Huang YJ; Zhang TY; Tan LB; Lu XF; Qin J
    World J Gastroenterol; 2019 Jul; 25(27):3590-3606. PubMed ID: 31367159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?
    Aron-Wisnewsky J; Warmbrunn MV; Nieuwdorp M; Clément K
    Gastroenterology; 2020 May; 158(7):1881-1898. PubMed ID: 32044317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Omega-3 Fatty Acids and Gut Microbiota: A Reciprocal Interaction in Nonalcoholic Fatty Liver Disease.
    Shama S; Liu W
    Dig Dis Sci; 2020 Mar; 65(3):906-910. PubMed ID: 32036510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.